[1] |
VANDERWAAL K, DEEN J. Global trends in infectious diseases of swine[J]. Proc Natl Acad Sci U S A, 2018, 115(45):11495-11500.
|
[2] |
MULUMBA-MFUMU L K, SAEGERMAN C, DIXON L K, et al. African swine fever:update on eastern, central and Southern Africa[J]. Transbound Emerg Dis, 2019, 66(4):1462-1480.
|
[3] |
CWYNAR P, STOJKOV J, WLAZLAK K. African swine fever status in Europe[J]. Viruses, 2019, 11(4):310.
|
[4] |
王清华, 任炜杰, 包静月, 等. 我国首例非洲猪瘟的确诊[J]. 中国动物检疫, 2018, 35(9):1-4.WANG Q H, REN W J, BAO J Y, et al. The first outbreak of African swine fever was confirmed in China[J]. China Animal Health Inspection, 2018, 35(9):1-4. (in Chinese)
|
[5] |
LI X D, TIAN K G. African swine fever in China[J]. Vet Rec, 2018, 183(9):300-301.
|
[6] |
BOINAS F S, HUTCHINGS G H, DIXON L K, et al. Characterization of pathogenic and non-pathogenic African swine fever virus isolates from Ornithodoros erraticus inhabiting pig premises in Portugal[J]. J Gen Virol, 2004, 85(8):2177-2187.
|
[7] |
GALLARDO C, SOLER A, RODZE I, et al. Attenuated and non-haemadsorbing (non-HAD) genotype Ⅱ African swine fever virus (ASFV) isolated in Europe, Latvia 2017[J]. Transbound Emerg Dis, 2019, 66(3):1399-1404.
|
[8] |
BORCA M V, CARRILLO C, ZSAK L, et al. Deletion of a CD2-like gene, 8-DR, from African swine fever virus affects viral infection in domestic swine[J]. J Virol, 1998, 72(4):2881-2889.
|
[9] |
MONTEAGUDO P L, LACASTA A, LÓPEZ E, et al. BA71ΔCD2:a new recombinant live attenuated African swine fever virus with cross-protective capabilities[J]. J Virol, 2017, 91(21):e01058-17.
|
[10] |
CHEN W Y, ZHAO D M, HE X J, et al. A seven-gene-deleted African swine fever virus is safe and effective as a live attenuated vaccine in pigs[J]. Sci China Life Sci, 2020, 63(5):623-634.
|
[11] |
SÁNCHEZ E G, PÉREZ-NU'EZ D, REVILLA Y. Development of vaccines against African swine fever virus[J]. Virus Res, 2019, 265:150-155.
|
[12] |
ARIAS M, DE LA TORRE A, DIXON L, et al. Approaches and perspectives for development of African swine fever virus vaccines[J]. Vaccines (Basel), 2017, 5(4):35.
|
[13] |
ROCK D L. Challenges for African swine fever vaccine development-"… perhaps the end of the beginning."[J]. Vet Microbiol, 2017, 206:52-58.
|
[14] |
GOATLEY L C, DIXON L K. Processing and localization of the African swine fever virus CD2v transmembrane protein[J]. J Virol, 2011, 85(7):3294-3305.
|
[15] |
RODRÍGUEZ J M, YÁ EZ R J, ALMAZÁN F, et al. African swine fever virus encodes a CD2 homolog responsible for the adhesion of erythrocytes to infected cells[J]. J. Virol, 1993, 67(9):5312-5320.
|
[16] |
MALOGOLOVKIN A, BURMAKINA G, TITOV I, et al. Comparative analysis of African swine fever virus genotypes and serogroups[J]. Emerg Infect Dis, 2015, 21(2):312-315.
|
[17] |
RUIZ-GONZALVO F, RODRÍGUEZ F, ESCRIBANO J M. Functional and immunological properties of the baculovirus-expressed hemagglutinin of African swine fever virus[J]. Virology, 1996, 218(1):285-289.
|
[18] |
MACEWAN S R, HASSOUNEH W, CHILKOTI A. Non-chromatographic purification of recombinant elastin-like polypeptides and their fusions with peptides and proteins from Escherichia coli[J]. J Vis Exp, 2014(88):e51583.
|
[19] |
LI G Y, XIAO Z Z, LU H P, et al. A simple method for recombinant protein purification using self-assembling peptide-tagged tobacco etch virus protease[J]. Protein Exp Purif, 2016, 128:86-92.
|
[20] |
ALEJO A, MATAMOROS T, GUERRA M, et al. A proteomic atlas of the African swine fever virus particle[J]. J Virol, 2018, 92(23):e01293-18.
|
[21] |
AFONSO C L, ALCARAZ C, BRUN A, et al. Characterization of p30, a highly antigenic membrane and secreted protein of African swine fever virus[J]. Virology, 1992, 189(1):368-373.
|
[22] |
THAPA A, HAN W, SIMONS R H, et al. Effect of detergents on the thermal behavior of elastin-like polypeptides[J].Biopolymers, 2013, 99(1):55-62.
|